SP
ORGS

SWS Partners’s Orgenesis Inc. Common Stock ORGS Stock Holding History

SWS Partners’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12
Closed -$1K – 332
2018
Q1 		$1K Buy
+12
New +$1.42K ﹤0.01% 367

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SFG
SevenBridge Financial Group Harrisburg, Pennsylvania $640M AUM 27.29% 1-Year Est. Return

SWS Partners's ORGS Position: Q2 2018 in Review

SWS Partners sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2018, closing a stake of 12 shares — an estimated $1K sold.

SWS Partners first reported a position in ORGS in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 10 funds tracked by Wall St. Rank hold ORGS as of Q2 2018.

  • SWS Partners reported no remaining Orgenesis Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • SWS Partners sold 12 Orgenesis Inc. Common Stock shares in Q2 2018, an estimated $1K.
  • SWS Partners first reported a position in Orgenesis Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • SWS Partners's Orgenesis Inc. Common Stock position peaked at $1K in Q1 2018.
  • 10 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2018.

Based on SWS Partners's 13F filing for Q2 2018, filed 13 Aug 2018.